---
$id: https://graph.org.ai/products/commodity/51141529
$type: Product
source: UNSPSC
code: "51141529"
title: "Trimethadione"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trimethadione

**UNSPSC Code**: 51141529
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C6H9NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R7GV3H6FQ4, chemically known as 3,5,5,-trimethyloxazolidine-2,4-dione but generally known as trimethadione, which bears US NIH Compound Identifier 5576. European Medicines Agency schedules Trimethadione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11307MIG. The term TRIMETHADIONE is an International Non-Proprietary Name. World Health Organization schedules trimethadione in its Anatomical Therapeutic Chemical (ATC) Classification. TRIMETHADIONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimethadione under HS 29349990 and SITC 51579. As of Q4 2014, TRIMETHADIONE remains the US FDA Preferred Term for this commodity. Trimethadione bears US NLM identifiers UMLS ID C0041038 and NCI Concept Code C47772. SMILES: O1C(C(=O)N(C1=O)C)(C)C.

